Chimerix to Report Second Quarter 2022 Financial Results and Provide an Operational Update on August 8, 2022

Rhea-AI Summary

Chimerix (CMRX) will host a live conference call on August 8, 2022, at 4:30 p.m. ET to discuss Q2 financial results and provide a business overview. This session will allow investors to gain insights into the company's performance for the quarter ending June 30, 2022. The call can be accessed via phone or live audio webcast. Chimerix focuses on developing medicines for patients with serious diseases, with its key program, ONC201, in clinical development for H3 K27M-mutant glioma.

Positive

• Upcoming conference call provides transparency on Q2 financial results.
• Focus on developing ONC201 for serious conditions may attract investor interest.

Negative

• None.

DURHAM, N.C., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on Monday, August 8, 2022 at 4:30 p.m. ET to report financial results for the second quarter ended June 30, 2022, and to provide a business overview.

To access the live conference call, please dial (646) 307-1963 (domestic) or (800) 715-9871 (international) at least five minutes prior to the start time, and refer to conference ID 1222397. A live audio webcast of the call will also be available on the Investors’ section of the Company's website, www.chimerix.com. An archived webcast will be available on the Chimerix website approximately two hours after the event.

About Chimerix

Chimerix is a biopharmaceutical company with a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The Company’s most advanced clinical-stage development program, ONC201, is in development for H3 K27M-mutant glioma.

CONTACTS:

Michelle LaSpaluto
919 972-7115
ir@chimerix.com

Will O’Connor
Stern Investor Relations
212-362-1200
will@sternir.com

FAQ

When is the Chimerix Q2 2022 financial results conference call?

The conference call is scheduled for August 8, 2022, at 4:30 p.m. ET.

How can I participate in the Chimerix earnings call?

You can join the conference call by dialing (646) 307-1963 for domestic calls or (800) 715-9871 for international calls, or via a live audio webcast on their website.

What is the purpose of the upcoming Chimerix conference call?

The call will report on Chimerix's financial results for Q2 2022 and provide a business overview.

What is ONC201 being developed for?

ONC201 is in clinical development for H3 K27M-mutant glioma.